Stocks and InvestingStocks and Investing
Thu, February 8, 2018
Wed, February 7, 2018
Tue, February 6, 2018
Mon, February 5, 2018
Fri, February 2, 2018
Thu, February 1, 2018

Geoff Meacham Maintained (VRTX) at Buy with Increased Target to $200 on, Feb 1st, 2018


Published on 2024-10-26 02:26:39 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of Barclays, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $180 to $200 on, Feb 1st, 2018.

Geoff, nor any peers, have made any analyst calls on VRTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30